New Assessment System in Measuring Symptom Distress in Cancer Patients
Measuring the Symptom Distress of Cancer Patients: Development of a New Assessment System
M.D. Anderson Cancer Center
6,500 participants
Apr 13, 1999
OBSERVATIONAL
Conditions
Summary
This trial studies how well a new assessment system (MDASI or other MD Anderson-developed PRO instrument) works in measuring symptoms and the impact on quality of life in cancer patients. Development of a new assessment system may provide more information about the common symptoms that may occur in patients due to cancer and its treatment and how the symptoms impact quality of life.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Complete interview
Complete quality of life assessment
Complete questionnaires
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT00505245